Non-cardiac surgery following drug-eluting coronary stent implantation-a question of timing?
作者信息
Mitchell Andrew J, Gillies Michael A, Cruden Nicholas L
机构信息
Department of Cardiology, Royal Infirmary of Edinburgh, Edinburgh, UK.
Department of Critical Care Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.
出版信息
J Thorac Dis. 2017 May;9(5):E461-E464. doi: 10.21037/jtd.2017.04.45.
Abstract
摘要
相似文献
1
Non-cardiac surgery following drug-eluting coronary stent implantation-a question of timing?药物洗脱冠状动脉支架植入术后的非心脏手术——时机问题？
J Thorac Dis. 2017 May;9(5):E461-E464. doi: 10.21037/jtd.2017.04.45.
2
Coronary stent implantation and adverse cardiac events after surgery.冠状动脉支架植入术与术后心脏不良事件。
Eur J Clin Invest. 2018 Dec;48(12):e13030. doi: 10.1111/eci.13030. Epub 2018 Oct 8.
3
Prospective and systematic analysis of unexpected requests for non-cardiac surgery or other invasive procedures during the first year after drug-eluting stent implantation.药物洗脱支架置入后 1 年内非心脏手术或其他有创操作意外请求的前瞻性、系统性分析。
Yonsei Med J. 2014 Mar;55(2):345-52. doi: 10.3349/ymj.2014.55.2.345.
4
Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery.既往冠状动脉支架植入术和非心脏手术患者的心脏事件。
Circ Cardiovasc Interv. 2010 Jun 1;3(3):236-42. doi: 10.1161/CIRCINTERVENTIONS.109.934703. Epub 2010 May 4.
5
Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.冠状动脉支架置入术后非心脏手术患者的主要不良心脏事件风险。
JAMA. 2013 Oct 9;310(14):1462-72. doi: 10.1001/jama.2013.278787.
6
Perioperative implications of newer generation drug-eluting coronary stents: A narrative review.新一代药物洗脱冠状动脉支架的围手术期影响：叙述性综述。
Anaesth Intensive Care. 2021 Sep;49(5):338-348. doi: 10.1177/0310057X20984792. Epub 2021 Jun 16.
7
The Incidence of Non-Cardiac Surgery in Patients Treated With Drug-Eluting Stents According to Age.接受药物洗脱支架治疗的患者非心脏手术发生率与年龄的关系
J Invasive Cardiol. 2019 Feb;31(2):E9-E14. doi: 10.25270/jic/18.00231.
8
Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial.血管内超声指导与血管造影指导依维莫司洗脱支架置入的效果：IVUS-XPL 随机临床试验。
JAMA. 2015 Nov 24;314(20):2155-63. doi: 10.1001/jama.2015.15454.
9
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents.血管内超声指导与药物洗脱支架置入术后临床结局的关系。
Circ Cardiovasc Interv. 2018 Nov;11(11):e006243. doi: 10.1161/CIRCINTERVENTIONS.117.006243.
10
Sirolimus-Versus Zotarolimus-Eluting Stents in Acute Coronary Syndromes With C Type Left Anterior Descending Artery Lesions: A Three-Year Clinical Follow-Up.西罗莫司洗脱支架与佐他莫司洗脱支架用于左前降支C型病变急性冠脉综合征的三年临床随访
Cardiol Res. 2012 Jun;3(3):116-122. doi: 10.4021/cr170w. Epub 2012 May 20.
本文引用的文献
1
Perioperative Aspirin for Prevention of Venous Thromboembolism: The PeriOperative ISchemia Evaluation-2 Trial and a Pooled Analysis of the Randomized Trials.围手术期使用阿司匹林预防静脉血栓栓塞：围手术期缺血评估-2试验及随机试验的汇总分析
Anesthesiology. 2016 Dec;125(6):1121-1129. doi: 10.1097/ALN.0000000000001352.
2
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016美国心脏病学会/美国心脏协会关于冠状动脉疾病患者双联抗血小板治疗持续时间的指南聚焦更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2016 Sep 6;68(10):1082-115. doi: 10.1016/j.jacc.2016.03.513. Epub 2016 Mar 29.
3
Association of Coronary Stent Indication With Postoperative Outcomes Following Noncardiac Surgery.非心脏手术后冠状动脉支架植入指征与术后结局的关联
JAMA Surg. 2016 May 1;151(5):462-9. doi: 10.1001/jamasurg.2015.4545.
4
Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery.围手术期使用低分子量肝素进行桥接对接受非心脏手术的支架置入患者心脏和出血结局的影响。
Thromb Haemost. 2015 Aug;114(2):423-31. doi: 10.1160/TH14-12-1057. Epub 2015 May 28.
5
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.药物洗脱支架置入后短期与长期双联抗血小板治疗：一项个体患者数据的两两比较和网络荟萃分析。
J Am Coll Cardiol. 2015 Mar 24;65(11):1092-102. doi: 10.1016/j.jacc.2014.12.046.
6
The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting.经皮冠状动脉介入治疗后非心脏手术不良心脏事件的增量风险。
J Am Coll Cardiol. 2014 Dec 30;64(25):2730-9. doi: 10.1016/j.jacc.2014.09.072.
7
Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry.接受手术的冠状动脉支架植入患者围手术期口服抗血小板治疗的管理及临床结局。一项多中心注册研究的结果
Thromb Haemost. 2015 Feb;113(2):272-82. doi: 10.1160/TH14-05-0436. Epub 2014 Oct 2.
8
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).2014年欧洲心脏病学会/欧洲麻醉学会非心脏手术心血管评估和管理指南：非心脏手术心血管评估和管理联合工作组，由欧洲心脏病学会（ESC）和欧洲麻醉学会（ESA）组成。
Eur Heart J. 2014 Sep 14;35(35):2383-431. doi: 10.1093/eurheartj/ehu282. Epub 2014 Aug 1.
9
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.载有佐他莫司的药物洗脱支架置入后双联抗血小板治疗 3 个月与 12 个月：OPTIMIZE 随机试验。
JAMA. 2013 Dec 18;310(23):2510-22. doi: 10.1001/jama.2013.282183.
10
Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.冠状动脉支架置入术后非心脏手术患者的主要不良心脏事件风险。
JAMA. 2013 Oct 9;310(14):1462-72. doi: 10.1001/jama.2013.278787.
Zotero 插件